Nascent Therapeutics
PrivateLast Round
Pre Seed
Sep 3, 2026
Total Funding Raised
$1.1M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Nascent Therapeutics operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Pre Seed round in September 2026.
Nascent Therapeutics is a biotechnology company developing small molecule therapies that regulate mitochondrial transfer between cells to treat neurodegenerative diseases, cancer, and other age-related conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nascent Therapeutics Comparables
Compare Nascent Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MitoSense, Inc. | 85% | |
| MitoNova Therapeutics | 80% | |
| Mitrix Bio | 79% |
For institutional investors. Book with your work email.
Nascent Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Nascent Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zinc | Pre Seed |
| University of East Anglia | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 3, 2026
$945K round led by Zinc
For institutional investors. Book with your work email.
Nascent Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nascent Therapeutics's valuation, stock price, and market status.
Is Nascent Therapeutics a public or private company?
Nascent Therapeutics is a private company.
What is the current stock price of Nascent Therapeutics?
Nascent Therapeutics is a private company, so its shares have no public market price. Caplight tracks Nascent Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nascent Therapeutics worth (valuation)?
Valuation information for Nascent Therapeutics is not publicly available.
Can I buy Nascent Therapeutics stock?
Nascent Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nascent Therapeutics's last funding round?
Nascent Therapeutics's most recent funding round was Pre Seed on September 3, 2026.
Who are the main investors in Nascent Therapeutics?
Key investors in Nascent Therapeutics include Zinc.
Will Nascent Therapeutics IPO soon?
No public IPO plans have been announced for Nascent Therapeutics.
How can I track Nascent Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Nascent Therapeutics's shares on secondary markets.